| pubmed-article:793957 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:793957 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:793957 | lifeskim:mentions | umls-concept:C0008312 | lld:lifeskim |
| pubmed-article:793957 | lifeskim:mentions | umls-concept:C0003261 | lld:lifeskim |
| pubmed-article:793957 | lifeskim:mentions | umls-concept:C0301872 | lld:lifeskim |
| pubmed-article:793957 | lifeskim:mentions | umls-concept:C0175668 | lld:lifeskim |
| pubmed-article:793957 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:793957 | lifeskim:mentions | umls-concept:C1706536 | lld:lifeskim |
| pubmed-article:793957 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:793957 | pubmed:dateCreated | 1977-2-26 | lld:pubmed |
| pubmed-article:793957 | pubmed:abstractText | In primary biliary cirrhosis, the primary immune response to the bacteriophage phi X 174 is normal but the secondary response is significantly reduced. The reduction is primarily of IgG antibody, while IgM is proportionately less affected. These changes may be the result of a reduction in helper T lymphocyte function and may contribute to the increase in the ratio of serum concentration of IgM to IgG. | lld:pubmed |
| pubmed-article:793957 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:793957 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:793957 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:793957 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:793957 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:793957 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:793957 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:793957 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:793957 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:793957 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:793957 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:793957 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:793957 | pubmed:language | eng | lld:pubmed |
| pubmed-article:793957 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:793957 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:793957 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:793957 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:793957 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:793957 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:793957 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:793957 | pubmed:issn | 0017-5749 | lld:pubmed |
| pubmed-article:793957 | pubmed:author | pubmed-author:JonesJ VJV | lld:pubmed |
| pubmed-article:793957 | pubmed:author | pubmed-author:ThomasH CHC | lld:pubmed |
| pubmed-article:793957 | pubmed:author | pubmed-author:PeacockD BDB | lld:pubmed |
| pubmed-article:793957 | pubmed:author | pubmed-author:HoldenRR | lld:pubmed |
| pubmed-article:793957 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:793957 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:793957 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:793957 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:793957 | pubmed:pagination | 844-8 | lld:pubmed |
| pubmed-article:793957 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:793957 | pubmed:meshHeading | pubmed-meshheading:793957-H... | lld:pubmed |
| pubmed-article:793957 | pubmed:meshHeading | pubmed-meshheading:793957-A... | lld:pubmed |
| pubmed-article:793957 | pubmed:meshHeading | pubmed-meshheading:793957-F... | lld:pubmed |
| pubmed-article:793957 | pubmed:meshHeading | pubmed-meshheading:793957-A... | lld:pubmed |
| pubmed-article:793957 | pubmed:meshHeading | pubmed-meshheading:793957-M... | lld:pubmed |
| pubmed-article:793957 | pubmed:meshHeading | pubmed-meshheading:793957-C... | lld:pubmed |
| pubmed-article:793957 | pubmed:meshHeading | pubmed-meshheading:793957-A... | lld:pubmed |
| pubmed-article:793957 | pubmed:meshHeading | pubmed-meshheading:793957-L... | lld:pubmed |
| pubmed-article:793957 | pubmed:meshHeading | pubmed-meshheading:793957-I... | lld:pubmed |
| pubmed-article:793957 | pubmed:meshHeading | pubmed-meshheading:793957-I... | lld:pubmed |
| pubmed-article:793957 | pubmed:meshHeading | pubmed-meshheading:793957-L... | lld:pubmed |
| pubmed-article:793957 | pubmed:meshHeading | pubmed-meshheading:793957-A... | lld:pubmed |
| pubmed-article:793957 | pubmed:meshHeading | pubmed-meshheading:793957-I... | lld:pubmed |
| pubmed-article:793957 | pubmed:year | 1976 | lld:pubmed |
| pubmed-article:793957 | pubmed:articleTitle | Immune response to phi X 174 in man. 5. Primary and secondary antibody production in primary biliary cirrhosis. | lld:pubmed |
| pubmed-article:793957 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:793957 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:793957 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:793957 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:793957 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:793957 | lld:pubmed |
